Literature DB >> 29723119

Novel dihydropyridine thioglycosides and their corresponding dehydrogenated forms as potent anti-hepatocellular carcinoma agents.

Galal H Elgemeie1, Dina H El-Naggar2.   

Abstract

A novel method for preparation of a new class of dihydropyridine thioglycosides and their corresponding dehydrogenated forms, via reaction of piperidinium salts of dihydropyridinethiones with 2,3,4,6-tetra-O-acetyl-α-D-gluco- and galactopyranosyl bromides has been studied. The evaluation of antiproliferative activity against HepG-2 cell lines (liver carcinoma cell lines) of the dihydropyridine thioglycosides and pyridine thioglycosides revealed that many of the thioglycosides have interesting antitumor activities specifically 5c, 5g, 5l, 5o, 5p, 7a, 7i, 7p, 8b, 8f, 8s, and 8v.

Entities:  

Keywords:  antimetabolites; dihydropyridine thioglycosides; dihydropyridinethiones; pyridine thioglycosides; pyridinethiones

Mesh:

Substances:

Year:  2018        PMID: 29723119     DOI: 10.1080/15257770.2018.1457161

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  2 in total

1.  Antiproliferative Activity of Some Newly Synthesized Substituted Nicotinamides Candidates Using Pyridine-2(1H) thione Derivatives as Synthon.

Authors:  Dina H Elnaggar; Ashraf M Mohamed; Naglaa A Abdel Hafez; Mohamed E Azab; Manar E A Elasasy; Hanem M Awad; Thoraya A Farghaly; Abd El-Galil E Amr
Journal:  ACS Omega       Date:  2022-03-16

2.  Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development.

Authors:  Weiran Liao; Zhitian Shi; Haoren Tang; Tiangen Wu; Cheng Zhang; Yutao He; Renchao Zou; Lin Wang
Journal:  J Oncol       Date:  2022-08-29       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.